Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1991. Start Trial.
Date Value
December 31, 2025 3.816B
December 31, 2024 2.375B
December 31, 2023 1.050B
December 31, 2022 4.893B
December 31, 2021 3.802B
December 31, 2020 2.610B
December 31, 2019 4.476B
December 31, 2018 3.538B
December 31, 2017 3.689B
December 31, 2016 4.895B
December 31, 2015 3.428B
December 31, 2014 1.845B
December 31, 2013 1.223B
December 31, 2012 1.706B
December 31, 2011 1.730B
December 31, 2010 1.208B
December 31, 2009 1.264B
December 31, 2008 1.371B
Date Value
December 31, 2007 1.184B
December 31, 2006 902.69M
December 31, 2005 850.75M
December 31, 2004 1.058B
December 31, 2003 835.96M
December 31, 2002 787.77M
December 31, 2001 623.82M
December 31, 2000 581.34M
December 31, 1999 246.29M
December 31, 1998 73.50M
December 31, 1997 69.66M
December 31, 1996 78.73M
December 31, 1995 24.01M
December 31, 1994 20.60M
December 31, 1993 21.33M
December 31, 1992 38.22M
December 31, 1991 39.05M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. 2.677B
AbbVie, Inc. 5.257B
Regeneron Pharmaceuticals, Inc. 8.611B
Vertex Pharmaceuticals, Inc. 6.611B
Amgen, Inc. 9.129B